DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹15,370 Cr | ₹13,400 Cr | ₹11,786 Cr | ₹10,959 Cr | ₹9,989 Cr |
What is the latest Profit & Loss Account Balance ratio of DIVIS LABORATORIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹15,370 Cr |
| Mar2025 | ₹13,400 Cr |
| Mar2024 | ₹11,786 Cr |
| Mar2023 | ₹10,959 Cr |
| Mar2022 | ₹9,989 Cr |
How is Profit & Loss Account Balance of DIVIS LABORATORIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹15,370 Cr | 14.70 | |
| Mar2025 | ₹13,400 Cr | 13.69 | |
| Mar2024 | ₹11,786 Cr | 7.55 | |
| Mar2023 | ₹10,959 Cr | 9.71 | |
| Mar2022 | ₹9,989 Cr | - | |
Compare Profit & Loss Account Balance of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹194,612.8 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| MANKIND PHARMA | ₹106,460.0 Cr | 1.2% | 6.6% | -5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.6% |
8.7% |
7.9% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses